Androgen resistance
A mutation in the DNA binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor positive androgen resistance
5
A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor negative androgen resistance
8
Substitution of arginine 839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance
10
Functional analysis of androgen receptor mutations that confer anti androgen resistance identified in circulating cell free DNA from prostate cancer patients
15
Reduced affinity of the androgen receptor for 5 alpha dihydrotestosterone but not methyltrienolone in a form of partial androgen resistance Studies on cultured genital skin fibroblasts
7
Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy
10
Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization
13
Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy
17
Complete testicular feminization caused by an amino terminal truncation of the androgen receptor with downstream initiation
9
High efficiency covalent radiolabeling of the human androgen receptor Studies in cultured fibroblasts using dihydrotestosterone 17 beta bromoacetate
8
Syndromes d’insensibilite aux androgenes: Aspects moleculaires
6
Polycystic Ovarian Syndrome: a new perspective
12
Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy
11
Androgen excess in pancreatic β cells and neurons predisposes female mice to type 2 diabetes
18
Clinical and Hormonal Profile of Hypogonadism
105
Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions
30
STATINS IN POLYCYSTIC OVARY SYNDROME
9
Testosterone replacement in male hypogonadism
5
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
19
Combined Androgen receptor blockade overcomes the resistance of breast cancer cells to palbociclib
11